For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Mesoblast, Inc

USPTO Granted Patents = 30

CIPO Patents = 92

EPO Patents = 28

Trademarks = 5

Forward Citations = 51

Loading Chart...

Loading Chart...

37 inventors (with patents filed for the assignee):

Silviu Itescu (18 out of 27 patents)

Ravi Krishnan (9 out of 14 patents)

Peter Ghosh (8 out of 22 patents)

4. Stan Gronthos (8 out of 20 patents)

5. Michael David Schuster (5 out of 5 patents)

6. Andrew Christopher William Zannettino (3 out of 5 patents)

7. Andrew Zannettino (3 out of 12 patents)

8. Andrew Zannetino (1 out of 1 patent)

9. Claude Bernard (1 out of 1 patent)

10. Songtao Shi (1 out of 15 patents)

11. John Paul Simmons (1 out of 2 patents)

12. Andrew Christopher Williem Zannettino (1 out of 1 patent)

13. Paul John Simmons (1 out of 1 patent)

14. Paul J Simmons (1 out of 10 patents)

15. Andrew Christopher Zannettino (0 patent)

30 patents: Sort by Forward Citations

1. 12275801 - Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase (2025-04-14),

2. 12220433 - Methods of generating, repairing and/or maintaining connective tissue in vivo (2025-02-11),

3. 11135249 - Methods for increasing osteoblastic function (2021-10-05),

4. 10849932 - Method of treating graft versus host disease (2020-12-01),

5. 10688134 - Methods of treating or preventing respiratory conditions (2020-06-23),

6. 10596199 - Methods of treating or preventing rheumatic disease (2020-03-24),

7. 10544394 - Method of increasing proliferation of bone marrow mononuclear cells expressing STRO1- (2020-01-28),

8. 10421946 - Perivascular mesenchymal precursor cells (2019-09-24),

9. 10220057 - Mesenchymal precursor cell (2019-03-05),

10. 10206951 - Methods of treating multiple sclerosis using STRO-1+ and TNAP+ multipotential cells (2019-02-19),

11. 10159696 - Methods for treating obesity and/or metabolic syndrome (2018-12-25),

12. 10105394 - Method of treating graft versus host disease (2018-10-23),

13. 10028979 - Methods of treating or preventing respiratory conditions (2018-07-24),

14. 9974812 - Methods of treating or preventing rheumatic disease (2018-05-22),

15. 9968640 - Method for treating or preventing a pancreatic dysfunction (2018-05-15),

Mesoblast is a leading global biotechnology company focused on developing innovative cellular medicines using mesenchymal lineage adult stem cells. Their proprietary technology platform aims to generate off-the-shelf cell-based therapies for the treatment of various diseases with significant unmet medical needs. Mesoblast's diverse pipeline includes candidates targeting cardiovascular conditions, immune-mediated and inflammatory disorders, orthopedic disorders, and oncology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

30 Patents

#247 in New York, NY

#616 in New York

#10,854 in US

#21,168 in the World

New York, NY, United States of America

Mesoblast, Inc

Forward Citations = 51

37 inventors:

Silviu Itescu (18 out of 27 patents)

Ravi Krishnan (9 out of 14 patents)

Peter Ghosh (8 out of 22 patents)

4. Stan Gronthos (8 out of 20 patents)

5. Michael David Schuster (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…